About
Simmunome offers a no-code SaaS platform that uses AI-driven simulations combining protein networks, multi-omics data, and clinical evidence to support drug target validation, clinical trial patient stratification, and biomarker discovery in drug development.
Explore Simmunome's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.